NCT00573768View on ClinicalTrials.gov

Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel in Patients With Acute Ankle Sprain

PHASE2CompletedINTERVENTIONAL

Enrollment

271

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

July 31, 2008

Conditions

Ankle Sprain

Interventions

DRUG

Diclofenac diethylamine 2.32% gel

Diclofenac diethylamine 2.32% gel twice daily

DRUG

Placebo

Vehicle 2 times daily

DRUG

Diclofenac diethylamine 2.32% gel / Placebo

Diclofenac diethylamine 2.32% gel once daily / Vehicle once daily

Trial Locations (29)

10589

Novartis Investigative Site, Berlin

10961

Novartis Investigative Site, Berlin

12247

Novartis Investigative Site, Berlin

12349

Novartis Investigative Site, Berlin

14163

Novartis Investigative Site, Berlin

14169

Novartis Investigative Site, Berlin

20357

Novartis Investigative Site, Hamburg

22143

Novartis Investigative Site, Hamburg

24576

Novartis Investigative Site, Bad Bramstedt

26160

Novartis Investigative Site, Bad Zwischenahn

40212

Novartis Investigative Site, Düsseldorf

44263

Novartis Investigative Site, Dortmund

44789

Novartis Investigative Site, Bochum

57074

Novartis Investigative Site, Siegen

61231

Novartis Investigative Site, Bad Nauheim

67466

Novartis Investigative Site, Lambrecht/Pfalz

76133

Novartis Investigative Site, Karlsruhe

78333

Novartis Investigative Site, Stockach

80333

Novartis Investigative Site, München

80339

Novartis Investigative Site, Munich

80538

Novartis Investigative Site, München

80798

Novartis Investigative Site, München

85072

Novartis Investigative Site, Eichstätt

87600

Novartis Investigative Site, Kaufbeuren

88709

Novartis Investigative Site, Meersburg

91413

Novartis Investigative Site, Neustadt/Aisch

97762

Novartis Investigative Site, Hammelburg

01129

Novartis Investigative Site, Dresden

04109

Novartis Investigative Site, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY